Full text
PDFPage 460P
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ahtee L., Buncombe G. Metoclopramide induces catalepsy and increases striatal homovanillic acid content in mice. Acta Pharmacol Toxicol (Copenh) 1974 Nov;35(5):429–432. doi: 10.1111/j.1600-0773.1974.tb00764.x. [DOI] [PubMed] [Google Scholar]
- Andén N. E., Bédard P. Influences of cholinergic mechanisms on the function and turnover of brain dopamine. J Pharm Pharmacol. 1971 Jun;23(6):460–462. doi: 10.1111/j.2042-7158.1971.tb08686.x. [DOI] [PubMed] [Google Scholar]
- CARLSSON A., LINDQVIST M. EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN. Acta Pharmacol Toxicol (Copenh) 1963;20:140–144. doi: 10.1111/j.1600-0773.1963.tb01730.x. [DOI] [PubMed] [Google Scholar]
- Casteels-Van Daele M., Jaeken J., Van der Schueren P., Van den Bon P. Dystonic reactions in children caused by metoclopramide. Arch Dis Child. 1970 Feb;45(239):130–133. doi: 10.1136/adc.45.239.130. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Costall B., Naylor R. J. Neuroleptic and non-neuroleptic catalepsy. Arzneimittelforschung. 1973 May;23(5):674–683. [PubMed] [Google Scholar]
- O'Keeffe R., Sharman D. F., Vogt M. Effect of drugs used in psychoses on cerebral dopamine metabolism. Br J Pharmacol. 1970 Feb;38(2):287–304. doi: 10.1111/j.1476-5381.1970.tb08517.x. [DOI] [PMC free article] [PubMed] [Google Scholar]